Pharma ITX Update

During this session, some crucial VAT developments will be on the agenda such as:

• Status update of the Boehringer VAT reclaim opportunity (in relation to the payment of pharmataxes/-contributions) throughout the EU.

• The latest updates on transfer pricing adjustments and VAT (with reference to the relevant CJEU case law).

• The impact of ViDA, in particular the Single VAT Registration pillar of the legislation, on your supply chain, including the link with clinical trials and the movement of own goods.

• Free supplies post-clinical trial, for compassionate use, for medical need, for seeking marketing approval, for charitable purposes, etc. and the impact on your right to deduct VAT.

• Latest customs updates.

• Brief update from our consulting colleagues on the EU Pharma package, including potential impacts from a(n) (indirect) tax perspective.

• Other relevant CJEU case law/recent positions.

 Don’t miss this opportunity to stay ahead of VAT developments that matter most to your business and to connect with peers in the sector.

Nathalie Wittock

Partner | Indirect Tax | Deloitte

Ninke Dekuyper

Senior Manager | Indirect Tax | Deloitte

This event qualifies for ITAA Continuous Professional Education purposes.

Deloitte Gateway

Luchthaven Brussel Nationaal 1 J

Zaventem, 1930

Belgium

If you have any questions or comments, please do not hesitate to contact Djellëza Morina.

Deloitte Academy

Email: academy@deloitte.be